Journey Medical Corp Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Journey Medical Corp (DERM) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $2.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-26
- Journey Medical Corp valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $2.20M, a 43.59% decline from fiscal 2024.
- Journey Medical Corp valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $3.90M, a 387.50% increase from fiscal 2023.
- Journey Medical Corp valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $800.00K, a 90.52% decline from fiscal 2022.
- Journey Medical Corp valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $8.44M, a 22.37% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $2.20M 10-K · filed 2026-03-26 | |
| 2024-12-31 | $3.90M 10-K · filed 2025-03-27 | |
| 2023-12-31 | $800.00K 10-K · filed 2024-03-29 | |
| 2022-12-31 | $8.44M 10-K · filed 2023-03-31 | |
| 2021-12-31 | $10.87M 10-K · filed 2023-03-31 | -$10.87M 10-K · filed 2022-03-28 |